Diffuse large B-cell lymphoma involving the central nervous system.

Primary central nervous system lymphoma in immunocompetent individuals: a single center experience. Int J Clin Exp Pathol (2013) 0.81

STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature (2008) 10.73

STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature (2009) 9.74

Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol (2002) 4.31

Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity (2011) 3.74

Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity (2012) 3.49

CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol (2003) 3.39

The dsRNA binding protein family: critical roles, diverse cellular functions. FASEB J (2003) 3.09

Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol (2013) 3.04

Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell (2013) 2.90

Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol (2007) 2.78

Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer (2009) 2.78

STING manifests self DNA-dependent inflammatory disease. Proc Natl Acad Sci U S A (2012) 2.59

Adrenocortical oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol (2004) 2.58

VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol Cell (2005) 2.55

Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nat Immunol (2008) 2.52

A FADD-dependent innate immune mechanism in mammalian cells. Nature (2004) 2.50

Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease. J Virol (2002) 2.44

STING recognition of cytoplasmic DNA instigates cellular defense. Mol Cell (2013) 2.18

CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol (2004) 2.16

Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity. J Virol (2003) 2.10

MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J Pathol (2010) 1.98

Defective translational control facilitates vesicular stomatitis virus oncolysis. Cancer Cell (2004) 1.93

DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog (2012) 1.80

Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One (2012) 1.80

Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol (2004) 1.77

Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol (2007) 1.76

Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy. Nat Med (2007) 1.74

Indeterminate cell tumor: a rare dendritic neoplasm. Am J Surg Pathol (2008) 1.68

Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7. J Immunol (2007) 1.62

Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol (2002) 1.57

The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Hum Pathol (2009) 1.56

Keratin expression in endocrine organs and their neoplasms. Endocr Pathol (2009) 1.54

Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study. Am J Clin Pathol (2004) 1.54

Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation. Am J Clin Pathol (2008) 1.52

Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas. Leuk Lymphoma (2010) 1.50

A new morphological variant of uterine PEComas with sex-cord-like pattern and WT1 expression: more doubts about the existence of uterine PEComas. Ann Diagn Pathol (2009) 1.49

Indeterminate cell tumor of the spleen. Hum Pathol (2011) 1.46

Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting. J Virol (2009) 1.46

Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol (2002) 1.45

Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Am J Surg Pathol (2005) 1.45

TBK1 protects vacuolar integrity during intracellular bacterial infection. PLoS Pathog (2007) 1.43

DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking. Proc Natl Acad Sci U S A (2013) 1.41

Lack of association of cytomegalovirus with human brain tumors. Mod Pathol (2005) 1.40

The STING pathway and regulation of innate immune signaling in response to DNA pathogens. Cell Mol Life Sci (2010) 1.38

Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity. Pharmacol Ther (2009) 1.37

Schwannoma of the adrenal gland: report of two cases. Am J Surg Pathol (2006) 1.31

STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma. Cancer Res (2011) 1.30

TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases. J Biol Chem (2010) 1.29

The cellular protein P58IPK regulates influenza virus mRNA translation and replication through a PKR-mediated mechanism. J Virol (2006) 1.28

Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res (2002) 1.26

Melanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR. Mol Ther (2005) 1.23

Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship. Am J Surg Pathol (2012) 1.21

Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol (2006) 1.20

Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol (2008) 1.18

Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates. Hum Gene Ther (2010) 1.18

Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases. Clinics (Sao Paulo) (2011) 1.17

Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1. J Virol (2014) 1.16

Incidental and concurrent malignant lymphomas discovered at the time of prostatectomy and prostate biopsy: a study of 29 cases. Am J Surg Pathol (2005) 1.16

Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry. Am J Surg Pathol (2008) 1.16

Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis. Am J Surg Pathol (2011) 1.16

Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancer. Mol Ther (2008) 1.16

Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virus. Hum Gene Ther (2010) 1.15

PKR in innate immunity, cancer, and viral oncolysis. Methods Mol Biol (2007) 1.15

NFAR-1 and -2 modulate translation and are required for efficient host defense. Proc Natl Acad Sci U S A (2008) 1.14

Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma. Blood (2005) 1.14

Challenges in array comparative genomic hybridization for the analysis of cancer samples. Genet Med (2007) 1.14

Evaluation of an attenuated vesicular stomatitis virus vector expressing interferon-beta for use in malignant pleural mesothelioma: heterogeneity in interferon responsiveness defines potential efficacy. Hum Gene Ther (2010) 1.14

Cutting edge: DNA sensing via the STING adaptor in myeloid dendritic cells induces potent tolerogenic responses. J Immunol (2013) 1.13

Myopericytoma of the kidney. Hum Pathol (2010) 1.12

Determining tissue of origin for metastatic cancers: meta-analysis and literature review of immunohistochemistry performance. Appl Immunohistochem Mol Morphol (2010) 1.10

Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases. Am J Surg Pathol (2011) 1.09

Primary and secondary T-cell lymphomas of the breast: clinico-pathologic features of 11 cases. Appl Immunohistochem Mol Morphol (2009) 1.09

STING-dependent signaling. Nat Immunol (2011) 1.08

The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene. Cancer Res (2003) 1.08

Geographic variation in Epstein-Barr virus-associated Burkitt's lymphoma in children from Brazil. Int J Cancer (2004) 1.06

Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B. Blood (2002) 1.05

Endoplasmic reticulum stress regulates the innate immunity critical transcription factor IRF3. J Immunol (2012) 1.04

Defects in translational regulation mediated by the alpha subunit of eukaryotic initiation factor 2 inhibit antiviral activity and facilitate the malignant transformation of human fibroblasts. Mol Cell Biol (2004) 1.03

CD3-positive large B-cell lymphoma. Am J Surg Pathol (2009) 1.03

B-cell and T-cell lymphomas of the breast: clinical--pathological features of 53 cases. Int J Surg Pathol (2008) 1.03

Emperipolesis in a case of B-cell lymphoma: a rare phenomenon outside of Rosai-Dorfman disease. Ann Diagn Pathol (2003) 1.03

S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma. Blood (2012) 1.02

DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): Comparison between 2 different antibodies. Appl Immunohistochem Mol Morphol (2010) 1.01

Histopathological findings in 29 lymph node biopsies with increased IgG4 plasma cells. Mod Pathol (2011) 1.00

Extranodal Rosai-Dorfman disease involving the bone marrow: a case report. Am J Surg Pathol (2006) 1.00

A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum (2006) 1.00

Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression. J Virol (2011) 1.00

Treg depletion-enhanced IL-2 treatment facilitates therapy of established tumors using systemically delivered oncolytic virus. Mol Ther (2008) 1.00

Myxoid solitary fibrous tumor: a clinicopathologic study of three cases. Virchows Arch (2009) 0.99

Distinct clonal origins of systemic mastocytosis and associated B-cell lymphoma. Leuk Res (2007) 0.99

A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32. Blood (2011) 0.99

Phosphorylation of the NFAR proteins by the dsRNA-dependent protein kinase PKR constitutes a novel mechanism of translational regulation and cellular defense. Genes Dev (2010) 0.99

Perineural invasion in aggressive skin carcinomas of the head and neck. Potentially dangerous but frequently overlooked. ORL J Otorhinolaryngol Relat Spec (2008) 0.98

Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle. J Virol (2006) 0.98

Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma. Clin Cancer Res (2011) 0.97

Imatinib treatment for gastrointestinal stromal tumour (GIST). J Cell Mol Med (2009) 0.97

Primary cutaneous blastoid mantle cell lymphoma-case report. Am J Dermatopathol (2009) 0.97

Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector. J Virol (2002) 0.97

Triple-negative breast carcinomas are a heterogeneous entity that differs between young and old patients. Clinics (Sao Paulo) (2010) 0.97